Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study

被引：0
|
作者：
Chunan Bian
Zhongyou Li
Youtao Xu
Jie Wang
Lin Xu
Hongbing Shen
机构：
[1] Nanjing Medical University-Affiliated Cancer Hospital,Department of Thoracic Surgery
[2] Jiangsu Key Laboratory of Molecular and Translational Cancer Research,undefined
[3] Nanjing Jiangbei Peoples’ Hospital,undefined
[4] The Public Health College of Nanjing Medical University,undefined
来源：
World Journal of Surgical Oncology | / 13卷
关键词：
Lung adenocarcinoma; Mutant ; Immunohistochemistry; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study
    Bian, Chunan
    Li, Zhongyou
    Xu, Youtao
    Wang, Jie
    Xu, Lin
    Shen, Hongbing
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [2] Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas
    Sasaki, S
    Yamamoto, H
    Kaneto, H
    Ozeki, I
    Adachi, Y
    Takagi, H
    Matsumoto, T
    Itoh, H
    Nagakawa, T
    Miyakawa, H
    Muraoka, S
    Fujinaga, A
    Suga, T
    Satoh, M
    Itoh, F
    Endo, T
    Imai, K
    ONCOLOGY REPORTS, 2003, 10 (01) : 21 - 25
  • [3] SMAD4 transcription is upregulated by p53
    Dandaleh, Fadi S.
    Calva-Cerqueira, Daniel
    Woodfield, George
    Weigel, Ronald J.
    Howe, James R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S119 - S119
  • [4] Sonic Hedgehog is the Most Sensitive and Specific Parameter in Pancreatic Ductal Adenocarcinoma, Compared to MUC1, p16, p53, and Smad4
    Izumi, S.
    Suzuka, I.
    Onoda, Y.
    Ohasi, R.
    Yamakawa, T.
    Oka, T.
    PANCREAS, 2012, 41 (07) : 1159 - 1159
  • [5] P53 and P16 alterations in lung cancer
    Niklinski, J
    Niklinska, W
    Chyczewski, L
    Chyczewska, E
    Laudanski, J
    ENDOCRINE DISRUPTERS AND CARCINOGENIC RISK ASSESSMENT, 2002, 340 : 178 - 187
  • [6] Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays
    Leversha, MA
    Fielding, P
    Watson, S
    Gosney, JR
    Field, JK
    JOURNAL OF PATHOLOGY, 2003, 200 (05): : 610 - 619
  • [7] Colorectal mucinous adenocarcinoma: The clinicopathologic features and significance of p16 and p53 expression
    Lam, Alfred King-Yin
    Ong, Kate
    Ho, Yik-Hong
    DISEASES OF THE COLON & RECTUM, 2006, 49 (09) : 1275 - 1283
  • [8] EXPRESSION OF p16 AND p53 IN GASTRIC CARCINOMA
    Ma Yu Gao Liping Song Yifeng Jing Jiong Wang ChunjiangFirst Department of SurgeryShengzhou Peoples Hospital Shengzhou
    中国现代医学杂志, 2003, (01) : 30 - 33+39
  • [9] SIGNIFICANCE OF IMMUNOHISTOCHEMICAL EXPRESSION OF Ki-67, p53 AND p16 IN CLINICAL OUTCOME OF MENINGIOMA
    Nguyen, Nathalie
    Moes, Gregory
    Villano, John Lee
    NEURO-ONCOLOGY, 2013, 15 : 159 - 160
  • [10] Clinical and Histopathological Correlation of p16 and p53 Expression in Oral Cancer
    Varun Kumar Agarwal
    Rohit Sharma
    GPS Gahlot
    Amiy Arnav
    Indian Journal of Surgical Oncology, 2021, 12 : 164 - 168
12345